HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells.

Abstract
The effector functions of natural killer (NK) cells are regulated by integrated signals across an array of stimulatory and inhibitory receptors interacting with target cell surface ligands. The regulatory effect of interferon-alpha (IFNalpha) and interferon-gamma (IFNgamma) on expression of the family of NKG2 receptors, stimulatory NKG2D receptor and inhibitory NKG2A receptor, and cytolysis of the target tumor cells (MICA+ and HLA-E+) were studied. Results show that IFNgamma and IFNalpha influence NK cell function differently. Interferon-alpha stimulates expression of stimulatory NKG2D receptors and inhibits the expression of inhibitory NKG2A receptors on NK cells. Contrary to the stimulatory effect of IFNalpha, IFNgamma inhibits cytolysis by NK cells of tumor cells expressing MICA or HLA-E cell surface proteins. Blocking NKG2D or NKG2A receptor activity with monoclonal antibodies partly attenuates the inhibitory effect of IFNgamma while promoting the effects of IFNalpha on NK cytolysis. These results show for the first time that IFNgamma negatively regulates NK cells through NKG2 receptors, and that the balance between stimulatory and inhibitory signals through the NKG2 family of receptors may be controlled by two opposing interferons. Modulating the balance between stimulatory and inhibitory signals through cell surface receptors on NK cells may open a new approach to NK cell-based biotherapy for cancer and infectious diseases.
AuthorsCai Zhang, Jian Zhang, Rui Sun, Jinbo Feng, Haiming Wei, Zhigang Tian
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 5 Issue 6 Pg. 1057-67 (Jun 2005) ISSN: 1567-5769 [Print] Netherlands
PMID15829421 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Interferon-alpha
  • KLRC1 protein, human
  • KLRK1 protein, human
  • Ligands
  • NK Cell Lectin-Like Receptor Subfamily C
  • NK Cell Lectin-Like Receptor Subfamily K
  • Receptors, Cell Surface
  • Receptors, Immunologic
  • Receptors, Natural Killer Cell
  • Recombinant Proteins
  • Interferon-gamma
Topics
  • Antibodies, Monoclonal (pharmacology)
  • Cell Line
  • Cell Separation
  • Flow Cytometry
  • Humans
  • Interferon-alpha (pharmacology)
  • Interferon-gamma (metabolism, pharmacology)
  • Killer Cells, Natural (drug effects, metabolism)
  • Ligands
  • NK Cell Lectin-Like Receptor Subfamily C
  • NK Cell Lectin-Like Receptor Subfamily K
  • Receptors, Cell Surface (drug effects)
  • Receptors, Immunologic (biosynthesis, drug effects, genetics)
  • Receptors, Natural Killer Cell
  • Recombinant Proteins
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: